Thanks, meshcan. How about a little more to consider?
I expect those shareholders unhappy with Nasrat and Elite about the SunGen asset acquisition by Mikah are those unhappy with the pivot away from ADF opioids. To that I say, it’s business; companies that are successful adapt and overcome obstacles and that means, sometimes, things do not turn out as planned. Show me a Fortune 100 firm and I will tell you a story about how they adapted at a critical moment.
In fact, as anyone familiar with strategy knows, it requires adaptation because situations present themselves and decisions have to be made; often on limited information. Grasping the situational context and reacting effectively is often the difference between the success or failure of a decision and an endeavor.
So it is that Elite was presented with a situation for which there was little time to make a decision. When it was determined that Elite had insufficient funds and no access to LPC, Nasrat understood that to allow SunGen’s solid dose line, that includes Adderall IR and XR, along with the potential of other drug development including generic Concerta, to be acquired by a firm that might prove a difficult partner was unacceptable; as was the potential loss of actual revenues that were now being realized and could turn the company into a notable generic drug company. The point was how to set in motion scenarios for Elite's success. Nasrat decided to use his company, Mikah, to acquire the assets and it was wise. Right now, it is likely Elite in engaged in scenario analysis to determine the best path forward. But, as should be clear when Nasrat announced that the generic Concerta would be Elite’s product, not Mikah’s, and that he hopes IR and XR will also be, that should make it clear that his focus, as Elite’s CEO, is on making the company as successful as possible. And, that his future and financial success can be much more robust with Elite being successful. All the noise that somehow Nasrat benefits more by nefarious actions is total and unmitigated BS, and completely absent an understanding of business.
THIS NOTE RESPONDS TO ANOTHER OF THE MANY MISAPPREHENSIONS OF REALITY. IT IS CAPITALIZED SO IT DOES NOT GET LOST IN READING THE POST…
THERE WAS NO LOAN FROM LPC FOR MIKAH TO DO THE ASSET ACQUISITION FROM SUNGEN…ONLY ELITE AS A COMPANY (NOT ITS CEO) WAS ABLE TO TAP INTO THE LPC FUNDING SOURCE. AND, EVEN ELITE COULD NOT DO THAT BECAUSE THE AGREEMENT SPECIFIES A TEN CENT MINIMUM P/S. AS WE KNOW AND, FOR THOSE WONDERING ABOUT THE PURPOSE OF P/S MANIPULATION, THE P/S HAS BEEN JUST BELOW THAT. OBTW: ONCE HUNAN JINGFENG (SUNGEN’S PARENT COMPANY) REJECTED THE STOCK OFFER AND ELITE COULD NOT ACCESS THE LPC FUNDING SOURCE TO COMPLETE THE SUNGEN ASSET ACQUISITION, THAT IS WHY NASRAT’S MOVE WITH MIKAH WAS A SPOT ON DECISION AND WILL ENABLE ELITE TO REALIZE THE SUCCESS THAT SHAREHOLDERS HAVE LONG BEEN WAITING FOR.
Simple, really...if you understand the business world...and I do.
N2K
AI
